Eric Coldwell
Stock Analyst at Baird
(5.00)
# 8
Out of 4,832 analysts
191
Total ratings
56.48%
Success rate
126%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $138.95 | +0.76% | 14 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $195 → $161 | $141.82 | +13.52% | 17 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Neutral | $192 → $160 | $132.23 | +21.00% | 20 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $156 → $170 | $148.41 | +14.55% | 12 | May 2, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $253 → $267 | $242.37 | +10.16% | 13 | Apr 30, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $340 → $313 | $291.73 | +7.29% | 18 | Apr 23, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $172.48 | +12.48% | 10 | Apr 23, 2025 | |
| OMI Owens & Minor | Maintains: Neutral | $10 → $11 | $7.00 | +57.14% | 17 | Mar 3, 2025 | |
| AHCO AdaptHealth | Maintains: Outperform | $14 → $16 | $8.94 | +78.97% | 10 | Feb 27, 2025 | |
| PINC Premier | Maintains: Neutral | $20 → $19 | $22.52 | -15.63% | 7 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $25 | $4.78 | +423.01% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $682.28 | +0.84% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $11.13 | +358.22% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $55.91 | -19.51% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $60.04 | +9.93% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.52 | +2,926.32% | 4 | Nov 10, 2017 |
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $138.95
Upside: +0.76%
IQVIA Holdings
May 7, 2025
Maintains: Neutral
Price Target: $195 → $161
Current: $141.82
Upside: +13.52%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $192 → $160
Current: $132.23
Upside: +21.00%
Cardinal Health
May 2, 2025
Maintains: Outperform
Price Target: $156 → $170
Current: $148.41
Upside: +14.55%
Labcorp Holdings
Apr 30, 2025
Maintains: Outperform
Price Target: $253 → $267
Current: $242.37
Upside: +10.16%
Medpace Holdings
Apr 23, 2025
Maintains: Neutral
Price Target: $340 → $313
Current: $291.73
Upside: +7.29%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $172.48
Upside: +12.48%
Owens & Minor
Mar 3, 2025
Maintains: Neutral
Price Target: $10 → $11
Current: $7.00
Upside: +57.14%
AdaptHealth
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $8.94
Upside: +78.97%
Premier
Feb 5, 2025
Maintains: Neutral
Price Target: $20 → $19
Current: $22.52
Upside: -15.63%
Dec 6, 2024
Downgrades: Neutral
Price Target: $28 → $25
Current: $4.78
Upside: +423.01%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $682.28
Upside: +0.84%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $11.13
Upside: +358.22%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $55.91
Upside: -19.51%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $60.04
Upside: +9.93%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.52
Upside: +2,926.32%